The prevelance and recognition of depression in primary care.

Indian J Psychiatry

GAUTAM AMIN, Resident, Department of Psychiatry, Medical College and S.S.G. Hospital, Baroda-390 001.

Published: October 1998

In a two stage study of depression, 200 patients attending primary care were randomly investigated. All patients were screened using Beck Depression Inventory (BDI) (Beck & Beamesderfer, 1974) and were interviewed using Clinical Interview for Depression (CID) (Paykel, 1985). Sixty (30%) patients crossed BDI threshold for moderate or severe depression. On CID, forty two (21%) had depression. Being women, divorced or widowed and belonging to unitary families are associated with increased depression. Unemployment and lack of confiding relationship were related to depression The more common manifestations of depression viz. depressed mood, lack of energy and fatigue, decline in work and interest and anorexia had poor discriminatory power for the diagnosis of depression. The depressed patients did not have excess nicotine or alcohol dependence. The treating physicians missed diagnosis of depression in more than two third of patients. Implication of the study for the training of primary care physicians are discussed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966689PMC

Publication Analysis

Top Keywords

primary care
12
depression
11
depression cid
8
depression depressed
8
diagnosis depression
8
patients
5
prevelance recognition
4
recognition depression
4
depression primary
4
care stage
4

Similar Publications

Background: Non-communicable diseases (NCDs) are the leading cause of death globally, and many humanitarian crises occur in countries with high NCD burdens. Peer support is a promising approach to improve NCD care in these settings. However, evidence on peer support for people living with NCDs in humanitarian settings is limited.

View Article and Find Full Text PDF

Background: Initiation of buprenorphine for treatment of opioid use disorder (OUD) in acute care settings improves access and outcomes, however patients who use methamphetamine are less likely to link to ongoing treatment. We describe the intervention and design from a pilot randomized controlled trial of an intervention to increase linkage to and retention in outpatient buprenorphine services for patients with OUD and methamphetamine use who initiate buprenorphine in the hospital.

Methods: The study is a two-arm pilot randomized controlled trial (N = 40) comparing the mHealth Incentivized Adherence Plus Patient Navigation (MIAPP) intervention to treatment as usual.

View Article and Find Full Text PDF

Background: Primary school students struggling with mental health are less likely than high school students to access mental health care, due to barriers such as mental health stigma and low mental health literacy among children and parents. The near universal reach of schools offers a potential avenue to increase access to mental health care through early identification. The potential risks of this approach also need to be understood.

View Article and Find Full Text PDF

Impact of hospital formulary intervention on carbapenem use: a segmented time-series analysis of consumption and a propensity score-matched non-inferiority study of treatment efficacy.

J Pharm Health Care Sci

January 2025

Laboratory of Clinical Pharmacy Education, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University, 5-9-1, Shirokane, Minato-ku, Tokyo, 108-8641, Japan.

Background: Pharmaceutical formularies play a crucial role in guiding medication use by balancing clinical effectiveness and cost efficiency. Although formulary implementation has been increasing in Japan, comprehensive evaluations of its impact on both clinical and economic outcomes are limited. This study aimed to assess the effect of introducing an antimicrobial formulary at Yokohama City University Hospital on antibiotic usage and treatment outcomes in intra-abdominal infections.

View Article and Find Full Text PDF

Background: Pain is a major challenge for patients with rheumatoid arthritis (RA), with many people suffering chronic pain. Current RA management guidelines focus on assessing and reducing disease activity using disease-modifying anti-rheumatic drugs (DMARDs). Consequently, pain care is often suboptimal, with growing evidence that analgesics are widely prescribed to patients with RA, despite potential toxicities and limited evidence for efficacy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!